Market Insights Health Hospitals Inpatient Care

Gastroenterology - China

China

In China, the Gastroenterology market is anticipated to witness a substantial growth in revenue, projected to reach €29.18bn in 2024.
This growth is expected to continue with an annual growth rate (CAGR 2024-2029) of 4.45%, ultimately resulting in a market volume of €36.28bn by 2029.
It is important to note that in comparison to other countries, in the United States is anticipated to generate the highest revenue in this market, with an estimated value of €56,090.00m in 2024.
China's gastroenterology market is experiencing a surge in demand for innovative diagnostic technologies and advanced treatment methods.

Key regions: Brazil, China, Europe, United Kingdom, Canada

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.